Parmax Pharma Ltd.
Snapshot View

View in App

Prices View details >>

34.00 -1.55 ▼-4.4%

02 February 2023, 04:01:00 PM
Volume: 751

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.parmaxpharma.com
Market Cap 12.72 Cr.
Enterprise Value(EV) 18.25 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -6.90 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.44 Trailing Twelve Months Ending 2022-09
Book Value / Share 6.51 Trailing Twelve Months Ending 2022-09
Price to Book Value 5.22 Calculated using Price: 34.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.37 Cr. 3,741,300 Shares
FaceValue 10
Company Profile
Parmax Pharma was incorporated on November 02, 1994. The certificate of commencement of business was received by the company on March 10, 1995.The IPO of the company was January 30, 1996 with 5100800 shares of Rs10/-each. The promoters were earlier in manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The company then discontinued its business activities for few years due to various reasons. The company also plans to extend its activity in formulation of Tablets, Capsules, Ointments, & Injectable.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.36%
1 Week
-3.13%
1 Month
-9.09%
3 Month
-6.46%
6 Month
+9.85%
1 Year
-35.85%
2 Year
+13.52%
5 Year
+100%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.16 0.70 -0.12 -0.28 0.02 3.71 18.19 22.55 3.38
Return on Capital Employed (%) 1.01 0.88 0.28 0.18 0.81 1.96 10.19 16.25 6.62
Return on Assets (%) 0.73 0.45 -0.08 -0.12 0.00 0.43 2.11 3.45 0.70

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4 4 5 5 5 5 5 6 6 4
Non Curr. Liab. 1 1 0 1 2 5 5 6 5 6
Curr. Liab. 0 0 0 2 10 10 11 11 7 6
Minority Int.
Equity & Liab. 5 5 5 8 17 20 21 23 18 16
Non Curr. Assets 3 3 3 3 6 9 10 11 11 11
Curr. Assets 2 2 2 4 9 9 9 10 7 5
Misc. Exp. not W/O 1 1 1 1 2 2 2 1 1
Total Assets 5 5 5 8 17 20 21 23 18 16

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 12 12 21 26 18 14
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 12 12 21 26 18 14
Total Expenditure 0 0 0 0 -11 -11 -19 -23 -16 -14
PBIDT 0 0 0 0 1 1 2 4 3 0
Interest 0 0 0 0 0 0
Depreciation -1 -1 -1 -2 -2 -2
Taxation 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 1 0 -3
Adjusted EPS 0 0 0 0 0 1 2 0 -7

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 4 1 3 4 1
Cash Fr. Inv. 0 -4 -3 -2 -3 -2
Cash Fr. Finan. 0 0 0 1 1 3 0 0 -1
Net Change 0 0 0 1 1 0 1 -2
Cash & Cash Eqvt 0 0 0 0 0 1 2 2 3 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 30.80 30.80 30.80 30.80 30.80 30.80 30.80 30.80 30.80
Public 69.20 69.20 69.20 69.20 69.20 69.20 69.20 69.20 69.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 17 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2022.
Fri, 30 Dec 2022
Closure of Trading Window
Subject: Closure of trading window
Sat, 24 Dec 2022
Clarification On Price Movement.
Clarification on Price Movement.

Technical Scans View Details >>

Thu, 02 Feb 2023
Opening at Low Opening at Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 1 Year High Decrease in 1 Year
High Increase in 5 Years High Increase in 5 Years
William %R Crossed -80 From Above William %R Crossed -80 From Above

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,852.96 1,008.00 -0.6%
Divi's Laboratories Ltd. 86,732.57 3,271.90 -2.5%
Cipla Ltd. 82,728.22 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. 72,771.66 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. 60,864.05 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. 52,144.29 1,541.15 +0.5%
Zydus Lifesciences Ltd. 43,787.95 432.60 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.42 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.03 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 31.36 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.95 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.52 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.77 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.59 432.60 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.37 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 3.65 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.17 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.63 432.60 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 432.60 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 432.60 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 432.60 -0.7%

FAQ's On Parmax Pharma Ltd.

What is Parmax Pharma share price?
Can I buy Parmax Pharma shares now?
What is the Market Cap of Parmax Pharma?
What are the key metrics to analyse Parmax Pharma?
What is the 52 Week High and Low of Parmax Pharma?
What is the trend of Parmax Pharma share price?